FACTANKER

US-Listed Services-Commercial Physical & Biological Research — EBITDA Margin Percentiles, FY 2023

Population: 12 US-listed companies (SIC 8731), fiscal year 2023; fiscal year ends 2023-09-30 to 2023-12-31.

Fiscal year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · latest

10th percentile-544.6%
25th percentile-246.0%
Median-47.9%
75th percentile19.4%
90th percentile22.4%
Mean-158.4%
Minimum-668.5%
Maximum30.9%
Methodology & sources
EBITDA margin = (operating income + depreciation & amortization) / revenue, all values as filed; computed in SQL per company, then percentiles. Fiscal year 2023 = fiscal years ending 2023-06-01 to 2024-05-31 (majority-overlap rule; June-ending fiscal years count toward the ending calendar year).
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, precomputed 2026-09-03.

Evidence samples

Latest EBITDA Margin percentiles (live) · All Services-Commercial Physical & Biological Research benchmarks · All industries

Cite as: FACTANKER, https://factanker.com/industries/sic-8731/ebitda-margin/2023